T-MAXIMUM
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. T-Maximum's gene-editing allogeneic immune cell therapy adopts the version 3.0 program with completely independent intellectual property rights to realize allogeneic universal CAR-T therapy and solve the risk of graft-versus-host disease and rejection of allogeneic immune cells.
T-MAXIMUM
Industry:
Biotechnology Health Care Product Research
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.t-maximum.com
Status:
Active
Contact:
400-9600-652
Total Funding:
0
Investors List
Hongfeng Investment Management
Hongfeng Investment Management investment in Angel Round - T-Maximum
Haibang Capital
Haibang Capital investment in Angel Round - T-Maximum
Official Site Inspections
http://www.t-maximum.com
- Host name: 47.238.209.36
- IP address: 47.238.209.36
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "T-Maximum"
T-Maximum 2025 Company Profile: Valuation, Funding …
T-Maximum General Information Description. Developer of CAR-T Cell therapies intended to treat brain tumors. The company has a unique universal CAR-T development platform, CRISPR/Cas9 Gene-Editing platform, which effectively …See details»
T-Maximum - Funding, Financials, Valuation & Investors
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... How much funding has …See details»
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
Mar 7, 2025 Explore T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Neoplasms, Hemic and …See details»
WuXi ATU and T-MAXIMUM Announce Strategic …
June 6, 2023 – Boston, Massachusetts. WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and T-MAXIMUM today signed a strategic collaboration …See details»
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
了解T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd. (T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 1篇新闻， …See details»
T-Maximum - Tech Stack, Apps, Patents & Trademarks - Crunchbase
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
T-Maximum - Web3 Crypto Company Profile, Funding, Valuation, …
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.See details»
T-MAXIMUM PHARMACEUTICAL Announces Latest Clinical …
Aug 8, 2024 In addition to MT027, T-MAXIMUM is advancing two other allogeneic CAR-T cell therapy candidates: MT026 and MT020. MT026 targets IL13Rα2 and is being developed for …See details»
GenScript Biotech and T-MAXIMUM Biotech Form Strategic …
Aug 9, 2023 GenScript's cGMP sgRNA reagent services enabled FDA-certified orphan drug designation (ODD) for T-MAXIMUM Biotech's MT207 CAR-T cell therapy. PISCATAWAY, N.J. …See details»
药明生基与茂行生物就通用型CAR-T产品达成战略合作｜Bilingual …
Jun 9, 2023 药明康德内容团队编辑日前，药明生基与茂行生物美国公司T-MAXIMUM Pharmaceutical（简称：T-MAXIMUM）共同宣布达成战略合作协议。药明生基将为茂行生物 ...See details»
T-Maximum - Updates, News, Events, Signals & Triggers
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.See details»
Home - T-Maximus
Years Experience 0 + Why Us Our Commitment to Excellence At T-Maximus, we go the extra mile, providing recruitment solutions that transcend boundaries and consistently exceed client …See details»
T-Maximus Overview | SignalHire Company Profile
T-Maximus has been to focus to all kind of requirements - Indian or Global in the manpower consulting and recruitment industry. The main drivers to our triumph are maximum standards …See details»
WuXi ATU and T-MAXIMUM Announce Strategic Partnership of …
"We are delighted to be a strategic partner with WuXi ATU,"said Dr. Xiaoyun Shang, CEO of T-MAXIMUM. "T-MAXIMUM's mission is to develop UCAR-T product for patients in need, and …See details»
GenScript Biotech and T-MAXIMUM Biotech Form Strategic …
Aug 9, 2023 T-MAXIMUM Biotech is a clinical-stage cell therapy development company with core technology published in top journals such as Nature, Nature Biotechnology, Nature …See details»
Executive Search - T-Maximus
Home Recruitment Services Executive Search Executive Search Elevating Your Leadership Team Discover the future of your organization with our executive search services. At T-Maximus, we …See details»
Loblaw introduces ‘T’ symbol to identify products impacted by tariffs
Mar 11, 2025 In a statement on LinkedIn, the CEO and president of Loblaw Companies Ltd., Per Bank, said the organization has created a tariff symbol (T) to help customers make choices on …See details»
T-Maximum - Crunchbase
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
How You Configure Career Development Pages Using Transaction …
For the Careers of Interest data source, you can also set the visibility of these attributes: . Job Alert Subscription: By default, the button for subscribing to job alerts isn't shown for any role …See details»
T-Maximus - Crunchbase Company Profile & Funding
T-Maximus is a company that operates in the staffing and recruiting industry. It focuses on meeting various requirements in the manpower consulting and recruitment industry, both in …See details»